CompletedNot Applicable

Remote Ischemic Preconditioning and Contrast Induced - Acute Kidney Injury in Patients Undergoing Elective PCI

Poland101 participantsStarted 2015-03-01

Plain-language summary

Prospective, randomized, sham-controlled clinical study was conducted to assess whether RIPC reduces the incidence of CI-AKI measured standard way of using SCr concentration but also with the use of serum NGAL as a new potential biomarker of kidney injury. Furthermore, the aim of investigation was to analyse the safety and clinical outcomes of RIPC after elective coronary angiography (CA) followed by percutaneous coronary intervention (PCI).

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * aged over 18 years * patients with stable angina pectoris * patients admitted to Intensive Cardiac Therapy Clinic Medical University of Lodz with intention of elective CA with follow-up PCI. Exclusion Criteria: * history of severe injuries up to 2 months before intervention * history of surgeries up to 2 months before intervention * history of cancer, * acute inflammation during hospitalization * chronic autoimmunologic diseases * patients needing hemodialysis * chronic kidney disease in stage 4 or 5 (eGFR\<30 ml/min/1,73m2) * peripheral vascular disease affecting upper limbs.

What they're measuring

Number of Participants With Contrast Induced-Acute Kidney Injury

Timeframe: 48 to 72 hours after contrast exposure

Trial details

NCT IDNCT03761368

SponsorMedical University of Lodz

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2018-06-30

Results submitted2020-06-12

View on ClinicalTrials.gov More Remote Ischemic Preconditioning trials